Delivery Order SPE2DE21D7010-SPE2D626F10D8
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $11,287.94 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. The contract, designated as Delivery Order 4570101607, involves the procurement of MODULUS spinal surgical products and is structured as a fixed-price agreement with economic price adjustment provisions to accommodate cost fluctuations in specialized medical device...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a $12,969.84 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of December 12, 2025. The delivery order, designated as MODULUS, represents procurement of specialized spinal surgical products and medical devices for Department of Defense and Department of Veterans...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $20,821.36 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated as Contract No. 4569849710 for MODULUS spinal surgical products, carries an ultimate completion date of November 18, 2025, and will be performed at Nuvasive's San Diego, California facility. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $5,477.02 on December 4, 2025, for the MODULUS spinal surgical product through the Defense Logistics Agency (DLA) Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by December 31, 2025, with performance occurring at Nuvasive's San Diego facility. The award carries no set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order contract valued at $7,358.52 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, with a completion date of October 24, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment mechanisms and covers the supply of the MODULUS spinal surgical product to support federal healthcare operations. This award...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 on December 11, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with economic price adjustment mechanisms, is scheduled for completion by January 2, 2026. This award was issued without set-aside restrictions, indicating competitive open market procurement. Nuvasive...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, was awarded a $11,287.94 fixed-price delivery order (Contract 4569593362) by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The delivery order, which includes economic price adjustment provisions, is designated for the MODULUS product line and has an ultimate completion date of September 23, 2025. The contract was awarded without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $43,480.80 fixed-price delivery order with economic price adjustment provisions by the Defense Logistics Agency Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 18, 2025. The award is designated as an M5 delivery order issued without set-aside restrictions, indicating competition in an open market procurement. Performance will be...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and services, has been awarded a delivery order valued at $22,408.89 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 22, 2025. The contract, which carries no set-aside designation, is for the delivery of MODULUS spinal medical products and is structured as a fixed-price agreement with economic price adjustment provisions. Performance is scheduled to conclude by October...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F10D8Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $22,128.07 on November 25, 2025, for the supply of MODULUS spinal surgical products and related medical devices. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by January 2, 2026, with performance conducted at Nuvasive's San Diego, California facility. The contract was issued without set-aside restrictions, demonstrating successful competition in open market procurement. Funding is provided by the Defense Logistics Agency Medical Supply Chain, which procures medical supplies and equipment for Department of Defense and Department of Veterans Affairs healthcare facilities. This delivery order is issued under Transplant Technology Inc.'s larger $8 million Blanket Purchase Agreement with the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity contract vehicle effective through March 2027. The BPA serves as a strategic procurement mechanism enabling streamlined ordering of Nuvasive's comprehensive portfolio of spinal fusion devices, implants, surgical instruments, and bone graft materials across DoD and VA medical facilities nationwide. Nuvasive has demonstrated sustained capability as a critical supplier to federal healthcare agencies, providing specialized spinal technologies that support advanced orthopedic and neurosurgical procedures essential to military medical readiness and veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 11/24/25 |